Dr. Maha Al-Molaiki
Dr. Maha Almolaiki holds a Doctor of Pharmacy (PharmD) and a Bachelor of Pharmacy (BPharm) from the College of Pharmacy at King Saud University. She also has a Master of Business Administration (MBA) - Entrepreneurship and Innovation from SBS Swiss Business School and is certified by the Saudi Commission for Health Specialties (SCFHS) with the Saudi Board Certificate in Internal Medicine Pharmacotherapy (SSC-PHP-IMP) and the Saudi Specialty of Clinical Pharmacy Practice (SSC-PhP). Her specialty in clinical pharmacy is Internal Medicine, where she has progressed through PGY1 and PGY2 residencies to become a Consultant Clinical Pharmacist-Internal Medicine (Dec 2022 - Present). Her current position is Deputy Program Director-Clinical Pharmacy-Internal Medicine at the Ministry of National Guard Health Affairs (MNG-HA), a role she has held since September 2023. Her research and education experience is marked by her membership in the Member-Internal Medicine Pharmacy Specialty Network (IMPSN) of the Saudi Society of Clinical Pharmacy (since Aug 2020), her service as a Chief Resident, PGY2 Residents (Oct 2018 - Sep 2019), and being a Member-Scientific Committee of the Saudi Society of Clinical Pharmacy (Apr 2024 - Sep 2024). She was also recognized for a Top Cited Article 2022-2023 in the Journal of the American College of Clinical Pharmacy (JACCP) for an article titled "Ambulatory care pharmacy in Saudi Arabia; definition, history, present, future potentials, and expected challenges". Additionally, she has received honors as an Adverse Drug Reaction (ADR) Top Reporter.